{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:05:28Z","timestamp":1762506328886,"version":"3.40.4"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,5,10]],"date-time":"2014-05-10T00:00:00Z","timestamp":1399680000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1758-2946-6-22","type":"journal-article","created":{"date-parts":[[2014,5,10]],"date-time":"2014-05-10T01:02:51Z","timestamp":1399683771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Using cheminformatics to predict cross reactivity of \u201cdesigner drugs\u201d to their currently available immunoassays"],"prefix":"10.1186","volume":"6","author":[{"given":"Matthew D","family":"Krasowski","sequence":"first","affiliation":[]},{"given":"Sean","family":"Ekins","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,5,10]]},"reference":[{"key":"597_CR1","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1515\/CCLM.2004.249","volume":"42","author":"S George","year":"2004","unstructured":"George S: Position of immunological techniques in screening in clinical toxicology. Clin Chem Lab Med. 2004, 42: 1288-1309.","journal-title":"Clin Chem Lab Med"},{"key":"597_CR2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.cll.2012.06.004","volume":"32","author":"SE Melanson","year":"2012","unstructured":"Melanson SE: The utility of immunoassays for urine drug testing. Clin Lab Med. 2012, 32: 429-447. 10.1016\/j.cll.2012.06.004.","journal-title":"Clin Lab Med"},{"key":"597_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0009-8981(01)00714-8","volume":"315","author":"CA Hammett-Stabler","year":"2002","unstructured":"Hammett-Stabler CA, Pesce AJ, Cannon DJ: Urine drug screening in the medical setting. Clin Chim Acta. 2002, 315: 125-135. 10.1016\/S0009-8981(01)00714-8.","journal-title":"Clin Chim Acta"},{"key":"597_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4065\/83.1.66","volume":"83","author":"KE Moeller","year":"2008","unstructured":"Moeller KE, Lee KC, Kissack JC: Urine drug screening: practical guide for clinicians. Mayo Clinic Proc. 2008, 83: 66-76. 10.4065\/83.1.66.","journal-title":"Mayo Clinic Proc"},{"key":"597_CR5","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1080\/10550887.2010.509277","volume":"29","author":"PL Tenore","year":"2010","unstructured":"Tenore PL: Advanced urine toxicology testing. J Addict Dis. 2010, 29: 436-448. 10.1080\/10550887.2010.509277.","journal-title":"J Addict Dis"},{"key":"597_CR6","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3109\/15563650.2012.713108","volume":"50","author":"AH Wu","year":"2012","unstructured":"Wu AH, Gerona R, Armenian P, French D, Petrie M, Lynch KL: Role of liquid chromatography-high-resolution mass spectrometry (LC-HR\/MS) in clinical toxicology. Clin Toxicol (Phila). 2012, 50: 733-742. 10.3109\/15563650.2012.713108.","journal-title":"Clin Toxicol (Phila)"},{"key":"597_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0378-4274(99)00205-2","volume":"112\u2013113","author":"AS Christophersen","year":"2000","unstructured":"Christophersen AS: Amphetamine designer drugs - an overview and epidemiology. Toxicol Lett. 2000, 112\u2013113: 127-131.","journal-title":"Toxicol Lett"},{"key":"597_CR8","first-page":"2013","volume":"2013","author":"O Cottencin","year":"2013","unstructured":"Cottencin O, Rolland B, Karila L: New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature. Curr Pharm Des. 2013, 2013: 2013-in press","journal-title":"Curr Pharm Des"},{"key":"597_CR9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.7326\/0003-4819-159-8-201310150-00707","volume":"159","author":"EW Gunderson","year":"2013","unstructured":"Gunderson EW: Synthetic Cannabinoids: A New Frontier of Designer Drugs. Ann Intern Med. 2013, 159: 563-564.","journal-title":"Ann Intern Med"},{"key":"597_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.forsciint.2013.04.015","volume":"231","author":"JB Zawilska","year":"2013","unstructured":"Zawilska JB, Wojcieszak J: Designer cathinones\u2013an emerging class of novel recreational drugs. Forensic Sci Int. 2013, 231: 42-53. 10.1016\/j.forsciint.2013.04.015.","journal-title":"Forensic Sci Int"},{"key":"597_CR11","first-page":"304","volume":"18","author":"L Kapka-Skrzypczak","year":"2011","unstructured":"Kapka-Skrzypczak L, Kulpa P, Sawicki K, Cyranka M, Wojtyla A, Kruszewski M: Legal highs - legal aspects and legislative solutions. Ann Agric Environ Med. 2011, 18: 304-309.","journal-title":"Ann Agric Environ Med"},{"key":"597_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/dta.1510","volume":"6","author":"LA King","year":"2013","unstructured":"King LA: Legal controls on cannabimimetics: An international dilemma?. Drug Test Anal. 2013, 6: 80-87.","journal-title":"Drug Test Anal"},{"key":"597_CR13","first-page":"28735","volume":"78","author":"United States Department of Justice","year":"2013","unstructured":"United States Department of Justice: Schedules of controlled substances: temporary placement of three synthetic cannabinoids into Schedule I. Final order. Fed Regist. 2013, 78: 28735-28739.","journal-title":"Fed Regist"},{"key":"597_CR14","unstructured":"Congress agrees to add 26 synthetic drugs to Controlled Substances Act. http:\/\/www.justice.gov\/dea\/pubs\/pressrel\/pr061912.html ,"},{"key":"597_CR15","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/FTD.0b013e3181f33411","volume":"32","author":"FT Peters","year":"2010","unstructured":"Peters FT, Martinez-Ramirez JA: Analytical toxicology of emerging drugs of abuse. Ther Drug Monit. 2010, 32: 532-539. 10.1097\/FTD.0b013e3181f33411.","journal-title":"Ther Drug Monit"},{"key":"597_CR16","volume-title":"PIHKAL: A Chemical Love Story","author":"A Shulgin","year":"1991","unstructured":"Shulgin A, Shulgin A: PIHKAL: A Chemical Love Story. 1991, Berkeley, CA: Transform Press"},{"key":"597_CR17","volume-title":"TIHKAL: The Continuation","author":"A Shulgin","year":"1997","unstructured":"Shulgin A, Shulgin A: TIHKAL: The Continuation. 1997, Berkeley, CA: Transform Press"},{"key":"597_CR18","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1056\/NEJMc1107097","volume":"365","author":"EA Ross","year":"2011","unstructured":"Ross EA, Watson M, Goldberger B: \u201cBath salts\u201d intoxication. N Engl J Med. 2011, 365: 967-968. 10.1056\/NEJMc1107097.","journal-title":"N Engl J Med"},{"key":"597_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jsat.2012.02.003","volume":"44","author":"GS Winder","year":"2012","unstructured":"Winder GS, Stern N, Hosanagar A: Are \u201cBath Salts\u201d the next generation of stimulant abuse?. J Subst Abuse Treat. 2012, 44: 42-45.","journal-title":"J Subst Abuse Treat"},{"key":"597_CR20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0960-894X(01)80155-4","volume":"4","author":"JW Huffman","year":"1994","unstructured":"Huffman JW, Dai D: Design, synthesis and pharmacology of cannabimimetic indoles. Bioorg Med Chem. 1994, 4: 563-566. 10.1016\/S0960-894X(01)80155-4.","journal-title":"Bioorg Med Chem"},{"key":"597_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/jat\/bks013","volume":"36","author":"KG Shanks","year":"2012","unstructured":"Shanks KG, Dahn T, Terrell AR: Detection of JWH-018 and JWH-073 by UPLC-MS-MS in postmortem whole blood casework. J Anal Toxicol. 2012, 36: 145-152. 10.1093\/jat\/bks013.","journal-title":"J Anal Toxicol"},{"key":"597_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.toxlet.2010.06.002","volume":"197","author":"I Vardakou","year":"2010","unstructured":"Vardakou I, Pistos C, Spiliopoulou C: Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett. 2010, 197: 157-162. 10.1016\/j.toxlet.2010.06.002.","journal-title":"Toxicol Lett"},{"key":"597_CR23","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/febs.12260","volume":"280","author":"P Pacher","year":"2013","unstructured":"Pacher P, Kunos G: Modulating the endocannabinoid system in human health and disease\u2013successes and failures. FEBS J. 2013, 280: 1918-1943. 10.1111\/febs.12260.","journal-title":"FEBS J"},{"key":"597_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.pnpbp.2012.04.017","volume":"39","author":"KA Seely","year":"2012","unstructured":"Seely KA, Lapoint J, Moran JH, Fattore L: Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry. 2012, 39: 234-243. 10.1016\/j.pnpbp.2012.04.017.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"597_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3109\/03602532.2013.839700","volume":"46","author":"LK Brents","year":"2014","unstructured":"Brents LK, Prather PL: The K2\/Spice Phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products. Drug Metab Rev. 2014, 46: 72-85. 10.3109\/03602532.2013.839700.","journal-title":"Drug Metab Rev"},{"key":"597_CR26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jchromb.2013.04.043","volume":"930","author":"Y Al-Saffar","year":"2013","unstructured":"Al-Saffar Y, Stephanson NN, Beck O: Multicomponent LC-MS\/MS screening method for detection of new psychoactive drugs, legal highs, in urine-Experience from the Swedish population. J Chromatogr B Analyt Technol Biomed Life Sci. 2013, 930: 112-120.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"597_CR27","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/dta.306","volume":"3","author":"C Bell","year":"2011","unstructured":"Bell C, George C, Kicman AT, Traynor A: Development of a rapid LC-MS\/MS method for direct urinalysis of designer drugs. Drug Test Anal. 2011, 3: 496-504. 10.1002\/dta.306.","journal-title":"Drug Test Anal"},{"key":"597_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/jms.1877","volume":"46","author":"S Dresen","year":"2011","unstructured":"Dresen S, Kneisel S, Weinmann W, Zimmermann R, Auwarter V: Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. J Mass Spectrom. 2011, 46: 163-171. 10.1002\/jms.1877.","journal-title":"J Mass Spectrom"},{"key":"597_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jchromb.2013.04.017","volume":"929","author":"M Dziadosz","year":"2013","unstructured":"Dziadosz M, Weller JP, Klintschar M, Teske J: Scheduled multiple reaction monitoring algorithm as a way to analyse new designer drugs combined with synthetic cannabinoids in human serum with liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2013, 929: 84-89.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"597_CR30","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/anatox\/35.7.487","volume":"35","author":"MA ElSohly","year":"2011","unstructured":"ElSohly MA, Gul W, Elsohly KM, Murphy TP, Madgula VL, Khan SI: Liquid chromatography-tandem mass spectrometry analysis of urine specimens for K2 (JWH-018) metabolites. J Anal Toxicol. 2011, 35: 487-495. 10.1093\/anatox\/35.7.487.","journal-title":"J Anal Toxicol"},{"key":"597_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jchromb.2012.07.002","volume":"903","author":"M Hutter","year":"2012","unstructured":"Hutter M, Kneisel S, Auwarter V, Neukamm MA: Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2012, 903: 95-101.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"597_CR32","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/anatox\/35.7.386","volume":"35","author":"SL Kacinko","year":"2011","unstructured":"Kacinko SL, Xu A, Homan JW, McMullin MM, Warrington DM, Logan BK: Development and validation of a liquid chromatography-tandem mass spectrometry method for the identification and quantification of JWH-018, JWH-073, JWH-019, and JWH-250 in human whole blood. J Anal Toxicol. 2011, 35: 386-393. 10.1093\/anatox\/35.7.386.","journal-title":"J Anal Toxicol"},{"key":"597_CR33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jchromb.2013.07.005","volume":"934","author":"P Kavanagh","year":"2013","unstructured":"Kavanagh P, Grigoryev A, Melnik A, Savchuk S, Simonov A, Rozhanets V: Detection and tentative identification of urinary phase I metabolites of phenylacetylindole cannabimimetics JWH-203 and JWH-251, by GC-MS and LC-MS\/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2013, 934: 102-108.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"597_CR34","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/jms.3020","volume":"47","author":"S Kneisel","year":"2012","unstructured":"Kneisel S, Auwarter V: Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction. J Mass Spectrom. 2012, 47: 825-835. 10.1002\/jms.3020.","journal-title":"J Mass Spectrom"},{"key":"597_CR35","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/jat\/bks068","volume":"36","author":"IA Lua","year":"2012","unstructured":"Lua IA, Lin SL, Lin HR, Lua AC: Replacing immunoassays for mephedrone, ketamines and six amphetamine-type stimulants with flow injection analysis tandem mass spectrometry. J Anal Toxicol. 2012, 36: 575-581. 10.1093\/jat\/bks068.","journal-title":"J Anal Toxicol"},{"key":"597_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-61779-934-1_9","volume":"902","author":"RA Middleberg","year":"2012","unstructured":"Middleberg RA, Homan J: Quantitation of amphetamine-type stimulants by LC-MS\/MS. Methods Mol Biol. 2012, 902: 105-114. 10.1007\/978-1-61779-934-1_9.","journal-title":"Methods Mol Biol"},{"key":"597_CR37","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/jat\/bkt062","volume":"37","author":"KG Shanks","year":"2013","unstructured":"Shanks KG, Behonick GS, Dahn T, Terrell A: Identification of Novel Third-Generation Synthetic Cannabinoids in Products by Ultra-Performance Liquid Chromatography and Time-of-Flight Mass Spectrometry. J Anal Toxicol. 2013, 37: 517-525. 10.1093\/jat\/bkt062.","journal-title":"J Anal Toxicol"},{"key":"597_CR38","doi-asserted-by":"publisher","first-page":"8463","DOI":"10.1007\/s00216-013-7272-8","volume":"405","author":"M Sundstrom","year":"2013","unstructured":"Sundstrom M, Pelander A, Angerer V, Hutter M, Kneisel S, Ojanpera I: A high-sensitivity ultra-high performance liquid chromatography\/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urine. Anal Bioanal Chem. 2013, 405: 8463-8474. 10.1007\/s00216-013-7272-8.","journal-title":"Anal Bioanal Chem"},{"key":"597_CR39","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00216-012-6548-8","volume":"405","author":"MJ Swortwood","year":"2013","unstructured":"Swortwood MJ, Boland DM, DeCaprio AP: Determination of 32 cathinone derivatives and other designer drugs in serum by comprehensive LC-QQQ-MS\/MS analysis. Anal Bioanal Chem. 2013, 405: 1383-1397. 10.1007\/s00216-012-6548-8.","journal-title":"Anal Bioanal Chem"},{"key":"597_CR40","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1373\/clinchem.2013.209965","volume":"59","author":"A Wohlfarth","year":"2013","unstructured":"Wohlfarth A, Pang S, Zhu M, Gandhi AS, Scheidweiler KB, Liu HF, Huestis MA: First Metabolic Profile of XLR-11, a Novel Synthetic Cannabinoid, Obtained by Using Human Hepatocytes and High-Resolution Mass Spectrometry. Clin Chem. 2013, 59: 1638-1648. 10.1373\/clinchem.2013.209965.","journal-title":"Clin Chem"},{"key":"597_CR41","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/jat\/31.4.208","volume":"31","author":"LG Apollonio","year":"2007","unstructured":"Apollonio LG, Whittall IR, Pianca DJ, Kyd JM, Maher WA: Matrix effect and cross-reactivity of select amphetamine-type substances, designer analogues, and putrefactive amines using the Bio-Quant direct ELISA presumptive assays for amphetamine and methamphetamine. J Anal Toxicol. 2007, 31: 208-213. 10.1093\/jat\/31.4.208.","journal-title":"J Anal Toxicol"},{"key":"597_CR42","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/anatox\/35.7.444","volume":"35","author":"S Kerrigan","year":"2011","unstructured":"Kerrigan S, Mellon MB, Banuelos S, Arndt C: Evaluation of commercial enzyme-linked immunosorbent assays to identify psychedelic phenethylamines. J Anal Toxicol. 2011, 35: 444-451. 10.1093\/anatox\/35.7.444.","journal-title":"J Anal Toxicol"},{"key":"597_CR43","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.forsciint.2011.11.003","volume":"217","author":"K Nakanishi","year":"2012","unstructured":"Nakanishi K, Miki A, Zaitsu K, Kamata H, Shima N, Kamata T, Katagi M, Tatsuno M, Tsuchihashi H, Suzuki K: Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View, and the Emit(R) assays for use in drug enforcement. Forensic Sci Int. 2012, 217: 174-181. 10.1016\/j.forsciint.2011.11.003.","journal-title":"Forensic Sci Int"},{"key":"597_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3109\/15563650.2013.768344","volume":"51","author":"M Petrie","year":"2013","unstructured":"Petrie M, Lynch KL, Ekins S, Chang JS, Goetz RJ, Wu AH, Krasowski MD: Cross-reactivity studies and predictive modeling of \u201cBath Salts\u201d and other amphetamine-type stimulants with amphetamine screening immunoassays. Clin Toxicol (Phila). 2013, 51: 83-91. 10.3109\/15563650.2013.768344.","journal-title":"Clin Toxicol (Phila)"},{"key":"597_CR45","unstructured":"Swortwood MJ, Hearn WL, Decaprio AP: Cross-reactivity of designer drugs, including cathinone derivatives, in commercial enzyme-linked immunosorbent assays. in press"},{"key":"597_CR46","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/jat\/bkt024","volume":"37","author":"A Arntson","year":"2013","unstructured":"Arntson A, Ofsa B, Lancaster D, Simon JR, McMullin M, Logan B: Validation of a novel immunoassay for the detection of synthetic cannabinoids and metabolites in urine specimens. J Anal Toxicol. 2013, 37: 284-290. 10.1093\/jat\/bkt024.","journal-title":"J Anal Toxicol"},{"key":"597_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-227X-9-5","volume":"9","author":"MD Krasowski","year":"2009","unstructured":"Krasowski MD, Pizon AF, Siam MG, Giannoutsos S, Iyer M, Ekins S: Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse\/toxicology screening in emergency medicine. BMC Emerg Med. 2009, 9: 5-","journal-title":"BMC Emerg Med"},{"key":"597_CR48","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1373\/clinchem.2008.118638","volume":"55","author":"MD Krasowski","year":"2009","unstructured":"Krasowski MD, Siam MG, Iyer M, Pizon AF, Giannoutsos S, Ekins S: Chemoinformatic methods for predicting interference in drug of abuse\/toxicology immunoassays. Clin Chem. 2009, 55: 1203-1213. 10.1373\/clinchem.2008.118638.","journal-title":"Clin Chem"},{"key":"597_CR49","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/FTD.0b013e31819c1b83","volume":"31","author":"MD Krasowski","year":"2009","unstructured":"Krasowski MD, Siam MG, Iyer M, Ekins S: Molecular similarity methods for predicting cross-reactivity with therapeutic drug monitoring immunoassays. Ther Drug Monit. 2009, 31: 337-344. 10.1097\/FTD.0b013e31819c1b83.","journal-title":"Ther Drug Monit"},{"key":"597_CR50","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1021\/ci7004498","volume":"48","author":"SW Muchmore","year":"2008","unstructured":"Muchmore SW, Debe DA, Metz JT, Brown SP, Martin YC, Hajduk PJ: Application of belief theory to similarity data fusion for use in analog searching and lead hopping. J Chem Inf Model. 2008, 48: 941-948. 10.1021\/ci7004498.","journal-title":"J Chem Inf Model"},{"key":"597_CR51","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1021\/ci034231b","volume":"44","author":"J Hert","year":"2004","unstructured":"Hert J, Willett P, Wilton DJ, Acklin P, Azzaoui K, Jacoby E, Schuffenhauer A: Comparison of fingerprint-based methods for virtual screening using multiple bioactive reference structures. J Chem Inform Comput Sci. 2004, 44: 1177-1185. 10.1021\/ci034231b.","journal-title":"J Chem Inform Comput Sci"},{"key":"597_CR52","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1039\/b409865j","volume":"2","author":"J Hert","year":"2004","unstructured":"Hert J, Willett P, Wilton DJ, Acklin P, Azzaoui K, Jacoby E, Schuffenhauer A: Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures. Org Biomol Chem. 2004, 2: 3256-3266. 10.1039\/b409865j.","journal-title":"Org Biomol Chem"},{"key":"597_CR53","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1758-2946-5-2","volume":"5","author":"A Seal","year":"2013","unstructured":"Seal A, Yogeeswari P, Sriram D, Consortium O, Wild DJ: Enhanced ranking of PknB Inhibitors using data fusion methods. J Cheminform. 2013, 5: 2-10.1186\/1758-2946-5-2.","journal-title":"J Cheminform"},{"key":"597_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/ci300547g","volume":"53","author":"P Willett","year":"2013","unstructured":"Willett P: Combination of similarity rankings using data fusion. J Chem Inf Model. 2013, 53: 1-10. 10.1021\/ci300547g.","journal-title":"J Chem Inf Model"},{"key":"597_CR55","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1093\/bioinformatics\/btq140","volume":"26","author":"SJ Swamidass","year":"2010","unstructured":"Swamidass SJ, Azencott CA, Daily K, Baldi P: A CROC stronger than ROC: measuring, visualizing and optimizing early retrieval. Bioinformatics. 2010, 26: 1348-1356. 10.1093\/bioinformatics\/btq140.","journal-title":"Bioinformatics"},{"key":"597_CR56","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jchromb.2005.07.007","volume":"824","author":"AH Ewald","year":"2005","unstructured":"Ewald AH, Peters FT, Weise M, Maurer HH: Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography\u2013mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2005, 824: 123-131. 10.1016\/j.jchromb.2005.07.007.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"597_CR57","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1080\/00498250600780191","volume":"36","author":"HT Kamata","year":"2006","unstructured":"Kamata HT, Shima N, Zaitsu K, Kamata T, Miki A, Nishikawa M, Katagi M, Tsuchihashi H: Metabolism of the recently encountered designer drug, methylone, in humans and rats. Xenobiotica. 2006, 36: 709-723. 10.1080\/00498250600780191.","journal-title":"Xenobiotica"},{"key":"597_CR58","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.pnpbp.2013.04.007","volume":"45","author":"R Lopez-Arnau","year":"2013","unstructured":"Lopez-Arnau R, Martinez-Clemente J, Carbo M, Pubill D, Escubedo E, Camarasa J: An integrated pharmacokinetic and pharmacodynamic study of a new drug of abuse, methylone, a synthetic cathinone sold as \u201cbath salts\u201d. Prog Neuropsychopharmacol Biol Psychiatry. 2013, 45: 64-72.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"597_CR59","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00007691-200404000-00007","volume":"26","author":"HH Maurer","year":"2004","unstructured":"Maurer HH, Kraemer T, Springer D, Staack RF: Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis. Ther Drug Monit. 2004, 26: 127-131. 10.1097\/00007691-200404000-00007.","journal-title":"Ther Drug Monit"},{"key":"597_CR60","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s00216-010-3636-5","volume":"397","author":"MR Meyer","year":"2010","unstructured":"Meyer MR, Wilhelm J, Peters FT, Maurer HH: Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography\u2013mass spectrometry. Anal Bioanal Chem. 2010, 397: 1225-1233. 10.1007\/s00216-010-3636-5.","journal-title":"Anal Bioanal Chem"},{"key":"597_CR61","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2174\/1389200054021825","volume":"6","author":"RF Staack","year":"2005","unstructured":"Staack RF, Maurer HH: Metabolism of designer drugs of abuse. Curr Drug Metab. 2005, 6: 259-274. 10.2174\/1389200054021825.","journal-title":"Curr Drug Metab"},{"key":"597_CR62","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.forsciint.2007.11.001","volume":"177","author":"K Zaitsu","year":"2008","unstructured":"Zaitsu K, Katagi M, Kamata T, Kamata H, Shima N, Tsuchihashi H, Hayashi T, Kuroki H, Matoba R: Determination of a newly encountered designer drug \u201cp-methoxyethylamphetamine\u201d and its metabolites in human urine and blood. Forensic Sci Int. 2008, 177: 77-84. 10.1016\/j.forsciint.2007.11.001.","journal-title":"Forensic Sci Int"},{"key":"597_CR63","doi-asserted-by":"publisher","first-page":"e21917","DOI":"10.1371\/journal.pone.0021917","volume":"6","author":"LK Brents","year":"2011","unstructured":"Brents LK, Reichard EE, Zimmerman SM, Moran JH, Fantegrossi WE, Prather PL: Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. PLoS One. 2011, 6: e21917-10.1371\/journal.pone.0021917.","journal-title":"PLoS One"},{"key":"597_CR64","doi-asserted-by":"publisher","first-page":"6381","DOI":"10.1021\/ac201377m","volume":"83","author":"KC Chimalakonda","year":"2011","unstructured":"Chimalakonda KC, Moran CL, Kennedy PD, Endres GW, Uzieblo A, Dobrowolski PJ, Fifer EK, Lapoint J, Nelson LS, Hoffman RS, James LP, Radominska-Pandya A, Moran JH: Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine. Anal Chem. 2011, 83: 6381-6388. 10.1021\/ac201377m.","journal-title":"Anal Chem"},{"key":"597_CR65","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1124\/dmd.112.047530","volume":"40","author":"KC Chimalakonda","year":"2012","unstructured":"Chimalakonda KC, Seely KA, Bratton SM, Brents LK, Moran CL, Endres GW, James LP, Hollenberg PF, Prather PL, Radominska-Pandya A, Moran JH: Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2\/Spice: identification of novel cannabinoid receptor ligands. Drug Metab Dispos. 2012, 40: 2174-2184. 10.1124\/dmd.112.047530.","journal-title":"Drug Metab Dispos"},{"key":"597_CR66","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.forsciint.2013.03.053","volume":"231","author":"M Jang","year":"2013","unstructured":"Jang M, Yang W, Choi H, Chang H, Lee S, Kim E, Chung H: Monitoring of urinary metabolites of JWH-018 and JWH-073 in legal cases. Forensic Sci Int. 2013, 231: 13-19. 10.1016\/j.forsciint.2013.03.053.","journal-title":"Forensic Sci Int"},{"key":"597_CR67","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1021\/ac2005636","volume":"83","author":"CL Moran","year":"2011","unstructured":"Moran CL, Le VH, Chimalakonda KC, Smedley AL, Lackey FD, Owen SN, Kennedy PD, Endres GW, Ciske FL, Kramer JB, Kornilov AM, Bratton LD, Dobrowolski PJ, Wessinger WD, Fantegrossi WE, Prather PL, James LP, Radominska-Pandya A, Moran JH: Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine. Anal Chem. 2011, 83: 4228-4236. 10.1021\/ac2005636.","journal-title":"Anal Chem"},{"key":"597_CR68","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.forsciint.2010.04.003","volume":"200","author":"T Sobolevsky","year":"2010","unstructured":"Sobolevsky T, Prasolov I, Rodchenkov G: Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Sci Int. 2010, 200: 141-147. 10.1016\/j.forsciint.2010.04.003.","journal-title":"Forensic Sci Int"},{"key":"597_CR69","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1021\/ac3037365","volume":"85","author":"A Wohlfarth","year":"2013","unstructured":"Wohlfarth A, Scheidweiler KB, Chen X, Liu HF, Huestis MA: Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS\/MS and library search. Anal Chem. 2013, 85: 3730-3738. 10.1021\/ac3037365.","journal-title":"Anal Chem"},{"key":"597_CR70","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","volume":"50","author":"R Mechoulam","year":"1995","unstructured":"Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J, Vogel Z: Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol. 1995, 50: 83-90.","journal-title":"Biochem Pharmacol"},{"key":"597_CR71","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"WA Devane","year":"1992","unstructured":"Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992, 258: 1946-1949. 10.1126\/science.1470919.","journal-title":"Science"},{"key":"597_CR72","volume-title":"Clinician\u2019s pocket drug reference 2008","author":"LG Gomella","year":"2008","unstructured":"Gomella LG, Haist S, Adams AG, Smith KM: Clinician\u2019s pocket drug reference 2008. 2008, New York: McGraw-Hill Companies"},{"key":"597_CR73","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1124\/dmd.106.012351","volume":"34","author":"C Chang","year":"2006","unstructured":"Chang C, Bahadduri PM, Polli JE, Swaan PW, Ekins S: Rapid identification of novel P-glycoprotein ligands. Drug Metab Dispos. 2006, 34: 1976-1984. 10.1124\/dmd.106.012351.","journal-title":"Drug Metab Dispos"},{"key":"597_CR74","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s11095-005-2505-y","volume":"22","author":"S Ekins","year":"2005","unstructured":"Ekins S, Johnston JS, Bahadduri P, D\u2019Souza VM, Ray A, Chang C, Swaan PW: In vitro and pharmacophore-based discovery of novel hPEPT1 inhibitors. Pharmaceut Res. 2005, 22: 512-517. 10.1007\/s11095-005-2505-y.","journal-title":"Pharmaceut Res"},{"key":"597_CR75","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1039\/b409813g","volume":"2","author":"A Bender","year":"2004","unstructured":"Bender A, Glen RC: Molecular similarity: a key technique in molecular informatics. Org Biomol Chem. 2004, 2: 3204-3218. 10.1039\/b409813g.","journal-title":"Org Biomol Chem"},{"key":"597_CR76","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.bjp.0707306","volume":"152","author":"S Ekins","year":"2007","unstructured":"Ekins S, Mestres J, Testa B: In silico pharmacology for drug discovery: applications to targets and beyond. Br J Pharmacol. 2007, 152: 21-37. 10.1038\/sj.bjp.0707306.","journal-title":"Br J Pharmacol"},{"key":"597_CR77","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2174\/138920307781369427","volume":"8","author":"AS Reddy","year":"2007","unstructured":"Reddy AS, Pati SP, Kumar PP, Pradeep HN, Sastry GN: Virtual screening in drug discovery - a computational perspective. Curr Protein Pept Sci. 2007, 8: 329-351. 10.2174\/138920307781369427.","journal-title":"Curr Protein Pept Sci"},{"key":"597_CR78","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1373\/clinchem.2004.031823","volume":"50","author":"NA Obuchowski","year":"2004","unstructured":"Obuchowski NA, Lieber ML, Wians FH: ROC curves in clinical chemistry: uses, misuses, and possible solutions. Clin Chem. 2004, 50: 1118-1125. 10.1373\/clinchem.2004.031823.","journal-title":"Clin Chem"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1758-2946-6-22\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1758-2946-6-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1758-2946-6-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T21:38:34Z","timestamp":1746221914000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/1758-2946-6-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,10]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["597"],"URL":"https:\/\/doi.org\/10.1186\/1758-2946-6-22","relation":{},"ISSN":["1758-2946"],"issn-type":[{"type":"electronic","value":"1758-2946"}],"subject":[],"published":{"date-parts":[[2014,5,10]]},"assertion":[{"value":"27 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"22"}}